Get started
Live feed
·
ANALYSTRatingvia Quantisnow
Generate Biomedicines Inc. logo

Morgan Stanley initiated coverage on Generate Biomedicines with a new price target

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Quantisnow market dataNASDAQ
Generate Biomedicines Inc. logo
GENB
Generate Biomedicines Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2026
Get push alerts for GENB

Follow GENB and get a push notification the moment its next story breaks.

Full GENB profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GENB (Generate Biomedicines Inc.) and more on Quantisnow.